Title: Taboo Topics: Cancer x Cannabis
Duration: 30 minutes

Let’s talk about cannabis as a supportive option for cancer and treatment side effects — because cannabis, marijuana, mary jane, pot, or however it may be referred to, needs to be a less stigmatized topic! So, we’re getting into the weeds to talk bluntly about the benefits cannabis may provide for symptoms and side effects.
 
Dr. Brooke Worster from Jefferson Health Sidney Kimmel Cancer Center, joins us for an expert-led discussion with our Iris Oncology Medical Director, Dr. Meera Ravindranathan, for an informative and insightful discussion around cannabis and cancer.


Our
Presenters

Brooke Worster, MD, FACPBrooke Worster, MD, FACP
Director, Division of Supportive Oncology
Department of Medical Oncology at Jefferson Health Sidney Kimmel Cancer Center (SKCC)

Dr. Brooke Worster completed her internal medicine and chief residency at Temple University and fellowships in both pain management and palliative medicine at MGH and Dana Farber Cancer Center. She is an associate professor of medicine at the Sidney Kimmel Cancer Center; and the Director of the Division of Supportive Oncology. She is happy to be a clinician-researcher – practicing Supportive Medicine and cancer pain management for cancer patients. She has federal and private grant funding to study the use, impact, and perceptions of cannabis in various complex patient populations. Additionally, she serves as program director for the Masters in Cannabis Medicine, Science, and Business at Jefferson College of Emerging Health Professions.

 

Meera Ravindranathan, MD
Medical Director
Iris Oncology

Dr. Meera Ravindranathan is a Medical Director at Iris. Dr. Ravindranathan has more than 15 years of experience treating a wide range of cancers. Dr. Ravindranathan is a graduate of the Virginia Commonwealth University School of Medicine. She then did her residency in Internal Medicine as well as fellowship training in medical oncology at the University of Texas Medical Branch. Dr. Ravindranathan worked in academia in the early part of her career where she was involved in research and teaching at the University of New Mexico Cancer Treatment Center. In addition, she was selected to complete the American Association for Cancer Research (AACR) Methods in Clinical Cancer Research Workshop. Dr. Ravindranathan has authored numerous articles that have been published in peer-reviewed journals. She then was in private practice in San Diego, California where she still participated in clinical trials but focused mainly on treating adult cancer patients. She maintains a part-time clinical practice in California. Her passion is delivering excellent care and quality improvement in medicine.